iCare USA’s EIDON Ultra-Widefield Lens module receives US FDA 510(k) approval

Article

The EIDON Ultra-Widefield Lens module from iCare USA has received 510(k) approval from the FDA for distribution in the US.

iCare USA’s EIDON Ultra-Widefield Lens module receives US FDA 510(k) approval

The EIDON Ultra-Widefield Lens module from iCare USA has received 510(k) approval from the FDA for distribution in the US.

The Ultra-Widefield lens enables infrared, autofluorescence and fluorescein angiography images with up to 200° panoramic view. The lens captures 120 degree images of the retina in a single shot or up to 200 degrees with the “Mosiac” feature. This shows small details, highlighting signs of pathology from the center to the periphery and enables EIDON diagnostics to surpass limitations of conventional diagnostic tools.

The EIDON from iCare is the first TrueColor Confocal system to combine standard fundus imaging with features of Scanning Laser Ophthalmoscopy (SLO) systems. The retinal imaging system provides widefield views in multiple imaging modalities.

The Ultra-Widefield lens can be retrofitted to most of the EIDON fundus imaging systems.

iCare offers clinicians ophthalmic diagnostic tools to detect glaucoma, diabetic retinopathy and age-related macular degeneration (AMD). Their portfolio includes automated TrueColor imaging devices, perimeters and handheld rebound tonometers.

More information about the EIDON Ultra-Widefield lens can be found on the iCare website.

Related Content: Gene Therapy | Retina | Cataract & Refractive

Related Videos
Ramin Tadayoni, MD, speaks with Sheryl Stevenson
Jennifer I. Lim, MD, FARVO, FASRS, Director of Retina Service, University of Illinois at Chicago
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center
Carl D. Regillo, MD, FACS, FASRS, Chief of Retina Service, Wills Eye Hospital, Philadelphia, PA
Arshad Khanani, MD, MA FASRS, on a virtual call
Diana Do, MD, Professor of Ophthalmology, Byers Eye Institute, Stanford University, discusses the PHOTON study results as presented AAO
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.